Who Paid My Doc
Skytrofa
Drug Endocrinology
NDC 73362-003-01
General payments
$1,514,352
Research payments
$9,409,527
Through program year 2025, $1,514,352 in general payments and $9,409,527 in research payments were reported against Skytrofa (Endocrinology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $231,686 | 1,257 |
| 2025 | Research | $1,543,705 | 558 |
| 2024 | General | $380,363 | 1,775 |
| 2024 | Research | $2,691,665 | 940 |
| 2023 | General | $502,345 | 1,736 |
| 2023 | Research | $3,141,590 | 273 |
| 2022 | General | $399,958 | 1,819 |
| 2022 | Research | $2,032,567 | 574 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,587 general · 2,345 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.